We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


deCODE biostructures Initiates Research Collaboration with Cubist Pharmaceuticals

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "deCODE biostructures Initiates Research Collaboration with Cubist Pharmaceuticals"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

deCODE biostructures, Inc. announces the signing of a collaborative research agreement with Cubist Pharmaceuticals. Under the terms of the agreement, deCODE biostructures will conduct gene to structure research on multiple proprietary targets.

Specifically, deCODE will be providing Cubist with access to deCODE’s expertise in conducting high-throughput crystallography experiments in parallel with the goal of solving multiple high resolution protein-ligand structures. deCODE will also facilitate the interpretation of X-ray structure models for structure-guided drug design efforts.